The 11th Annual KASBP Symposium
(Hosted by KASBP, Daewoong, and Green Cross)
Symposium Program
Oct. 28 (Fri.) – Oct. 29 (Sat.), 2011
Sheraton Edison Hotel-Raritan Center, NJ
Korean American Society in Biotech and Pharmaceuticals (KASBP)
Daewoong Pharmaceutical Co., Ltd. (대웅제약)
Green Cross Co. (녹십자)
Korea Health Industry Development Institute(KHIDI, 한국보건산업진흥원)
Korean–American Scientists and Engineers Association (KSEA)
Korea-U.S. Science Cooperation Center (KUSCO)
For the latest information, please visit the website at:
Invitation Letter from KASBP Symposium-Organizing Committee
Following the success of prior conferences, Korean American Society in Biotech and Pharmaceuticals (KASBP) cordially invites all members and friends to the 11th Annual KASBP Symposium, hosted by KASBP, Daewoong Pharmaceutical Co. Ltd., and Green Cross Co., and sponsored by KHIDI (한국보건산업진흥원), KSEA, and KUSCO.
This symposium will focus on current trends in drug discovery and the development of young bio-pharmaceutical professionals. This year, the symposium has successfully recruited outstanding speakers to cover R&D collaboration strategy, current status of anti-inflamatory drugs, development of a new HCV drug, innovation of process chemistry, ADME evaluation tools, and drug approval process by FDA.
Prof. Sung-Hou Kim (김성호), a recipient of 2011 KASBP-Daewoong Achievement Award, will give a presentation with the title: Discovery of A “Personalized” Cancer Drug for Metastatic Melanoma. One of highlights of the symposium is round table discussion with FDA reviewers on new drug approval process. Another meaningful event is presenting the KASBP-Daewoong and KASBP-Green Cross fellowship awards to young scholars such as graduate students, post-docs, and industrial scientists who exhibit excellence in research.
This symposium will provide an opportunity for members to establish professional networks, and share information and experiences amongst members in pursuit of excellence in research and development. Please mark your calendar for this exciting symposium.
2011 KASBP symposium organizing committee
Symposium Schedule at a Glance
Friday Oct. 28, 2011
05:30 pm – 06:30 pm Registration & Reception with Cocktail
06:30 pm – 07:40 pm Opening, Dinner & Congratulatory Remarks
07:40 pm – 08:40 pm Keynote Speech
08:40 pm – 09:00 pm Daewoong Presentation
09:00 pm – 09:20 pm Green Cross Presentation
09:30 pm – 10:30 pm Round Table Discussion
Saturday Oct. 29, 201
08:30 am – 09:00 am Registration & Light Breakfast
09:00 am – 09:10 am Opening Remarks
09:10 am – 10:30 am Oral Session (I) Presentation 1, 2
10:30 am – 10:50 am Coffee Break
10:50 am – 11:00 am Fellowship Award Ceremony
11:00 am – 12:00 pm Oral Session (II) Six Short Presentations by Fellowship Awardees
12:00 pm – 01:30 pm Lunch & Poster Session
01:30 pm – 03:30 pm Oral Session (III) Presentation 3, 4, 5
03:30 pm – 04:00 pm Coffee Break & Poster Session
04:00 pm – 05:20 pm Oral Session (IV) Presentation 6, 7
05:20 pm – 05:30 pm Closing Remarks
06:00 pm – 09:00 pm Dinner
Oct. 28, 2011 (Friday)
Registration & Reception Cocktail
5:30 pm ~ 6:30 pm
Coordinators: Cheol K. Chung, Merck; Jong-Rock Kong, Merck; Sung Shim, BMS
Opening & Congratulatory Remarks and Dinner
6:30 pm ~ 7:40 pm
KASBP President-Designated: Hanjo Lim, Sanofi
KASBP President: Yong-Hae Han, BMS
Daewoong President: Jong-Wook Lee, Daewoong Pharmaceutical
Green Cross CTO: Eun Chul Huh, Green Cross Co.
KHIDI-NY Director: Do Hyun Cho, KHIDI
KSEA-NJ President Hongyong Kim, KSEA
Keynote Speech
7:40 pm ~ 8:40 pm
Award Lecture (KASBP-Daewoong Achievement Award 2011)
“Discovery Process of a ”Personalized” Cancer Drug For Metastatic Melanoma, Zelboraf”
Sung-Hou Kim
University of California, Berkeley, CA and WCU Program, Graduate School, Yonsei University, Seoul, Korea
8:40 pm ~ 9:00 pm
Daewoong Presentation
TBD
9:00 pm ~ 9:20 pm
Green Cross Presentation
TBD
9:30 pm ~ 10:30 pm
Round Table Discussion
Oct. 29, 2011 (Saturday)
Registration & Light Breakfast
8:30 am ~ 9:00 am
Coordinators: Cheol K. Chung, Merck; Jong-Rock Kong, Merck; Sung Shim, BMS
Opening Remarks
9:00 am ~ 9:10 am
Yong-Hae Han, BMS
Oral Session (I) – Chair : Yong-Hwan Jin, GSK
9:10 am ~ 10:30 am
“Best Practices of a Successful R&D Collaboration”
Charles D. Conover, Enzon Pharmaceuticals, Inc.
“Current Strategies for Inflammatory Disease-Focused Drug Discovery”
Sung-Kwon Kim, Merck
Coffee Break
10:30 am ~ 10:50 am
Fellowship Award Ceremony
10:50 am ~ 11:00 am
Organizer: Hanjo Lim, Sanofi
Oral Session (II) - Chair : Jae-Hun Kim, Merck
11:00 am ~ 12:00 pm
6 Oral Presentations By Fellowship Awardees (10 min each)
Lunch & Poster Session
12:00 pm ~ 1:30 pm
Oral Session (III) - Chair : Moo Je Sung, Norvatis
1:30 pm ~ 3:30 pm
“2’-alfa-F-2’-beta-C-Methyl Nucleotide Prodrugs for the Treatment of HCV Infection: From Discovery to the Clinic”
Byoung Kwon Chun, Pharmasset, Inc.
“Innovation on the Process Research and Development”
Jae-Moon Lee, Eisai Inc. USA
“Strategy of Utilizing In Vitro and In Vivo ADME Tools for Desirable Drug Candidate Selection”
Mi-Sook Kim, Millennium Pharmaceuticals
Coffee Break & Poster Session
3:30 pm ~ 4:00 pm
Oral Session (IV) – Chair : Nakyen Choy, PTC Therapeutics
4:00 pm ~ 5:20 pm
“Drug Development in the 21st Century: Industry-FDA Interactions”
Hae-Young Ahn, FDA
“Microdosing in Investigational Clinical Trials: Challenges and Perspectives”
Young-Moon Choi, FDA
Closing Remarks
5:20 pm ~ 5:30 pm
KASBP President: Yong-Hae Han, BMS
Dinner
Ichiumi Restaurant
352 Menlo Park Dr (Menlo Park Mall), Edison, NJ 08837 (Tel. 732.906.2370)